[
  {
    "title": "Vertex keeps outlook unchanged as income and revenue rise",
    "published": 1715097240,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.5391807556152344
  },
  {
    "title": "Q1 2024 Vertex Pharmaceuticals Inc Earnings Call",
    "published": 1715089841,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.6589323282241821
  },
  {
    "title": "Vertex Pharmaceuticals price target raised by $18 at Leerink, here's why",
    "published": 1715079180,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.7024036049842834
  },
  {
    "title": "Vertex Pharmaceuticals price target raised by $7 at RBC Capital, here's why",
    "published": 1715070600,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.7107131481170654
  },
  {
    "title": "Vertex Pharmaceuticals price target raised by $11 at UBS, here's why",
    "published": 1715068620,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.7293819189071655
  },
  {
    "title": "Oppenheimer Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)",
    "published": 1715066280,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.9144737124443054
  },
  {
    "title": "Piper Sandler Releases a Buy Rating on Vertex Pharmaceuticals (VRTX)",
    "published": 1715065740,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.9108092784881592
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Gets a Hold from RBC Capital",
    "published": 1715065680,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.9371644854545593
  },
  {
    "title": "Buy Rating on Vertex Pharmaceuticals: Promising Kidney Disease Treatments Poised for Market Growth",
    "published": 1715065380,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.9459986686706543
  },
  {
    "title": "Vertex Pharmaceuticals price target raised by $6 at Piper Sandler, here's why",
    "published": 1715060160,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.7308400869369507
  },
  {
    "title": "Buy Rating Affirmed for Vertex Pharmaceuticals on Strong Q1 Earnings and Expanding Market Presence",
    "published": 1715052360,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 406.1203918457031,
      "2024-05-07T14:30:00+00:00": 406.3999938964844,
      "2024-05-07T15:30:00+00:00": 412.6300048828125,
      "2024-05-07T16:30:00+00:00": 410.760009765625,
      "2024-05-07T17:30:00+00:00": 411.5400085449219,
      "2024-05-07T18:30:00+00:00": 409.44000244140625,
      "2024-05-07T19:30:00+00:00": 408.94500732421875
    },
    "sentiment": 0.9552577137947083
  },
  {
    "title": "UPDATE 1-Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments",
    "published": 1715034798,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.9421020746231079
  },
  {
    "title": "Vertex Pharmaceuticals, Inc. (VRTX) Q1 2024 Earnings Call Transcript",
    "published": 1715031062,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.8932909965515137
  },
  {
    "title": "Vertex Beats Quarterly Forecasts, But Its Pipeline Remains Key",
    "published": 1715029147,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.941871702671051
  },
  {
    "title": "Vertex Reports First Quarter 2024 Financial Results",
    "published": 1715025660,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.8881224393844604
  },
  {
    "title": "Vertex Pharmaceuticals 1Q Sales Up 13% on Cystic Fibrosis Drug",
    "published": 1715013512,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.9292699098587036
  },
  {
    "title": "Smart Money Is Betting Big In VRTX Options",
    "published": 1714994460,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.6995221376419067
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Owens & Minor (OMI), Vertex Pharmaceuticals (VRTX) and Aldeyra Therapeutics (ALDX)",
    "published": 1714972860,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.9101052284240723
  },
  {
    "title": "Vertex provides another EPS beat as net income rises 56% in Q1",
    "published": 1714969320,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.9451616406440735
  },
  {
    "title": "Vertex Pharmaceuticals affirms FY4 revenue view of $10.55B-$10.75B",
    "published": 1714964640,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.6595264077186584
  },
  {
    "title": "Noteworthy Monday Option Activity: VRTX, VRT, BOWL",
    "published": 1714962720,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 402.29998779296875,
      "2024-05-06T14:30:00+00:00": 402.70001220703125,
      "2024-05-06T15:30:00+00:00": 402.6700134277344,
      "2024-05-06T16:30:00+00:00": 401.8900146484375,
      "2024-05-06T17:30:00+00:00": 403.7099914550781,
      "2024-05-06T18:30:00+00:00": 404.8699951171875,
      "2024-05-06T19:30:00+00:00": 403.0400085449219
    },
    "sentiment": 0.9119530916213989
  },
  {
    "title": "Insider Sale at Vertex Pharmaceuticals Inc (VRTX): Director Sangeeta Bhatia Sells Shares",
    "published": 1714777267,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 401.5,
      "2024-05-03T14:30:00+00:00": 399.70001220703125,
      "2024-05-03T15:30:00+00:00": 399.93499755859375,
      "2024-05-03T16:30:00+00:00": 400.2200012207031,
      "2024-05-03T17:30:00+00:00": 401.6600036621094,
      "2024-05-03T18:30:00+00:00": 402.04998779296875,
      "2024-05-03T19:30:00+00:00": 402.1099853515625
    },
    "sentiment": 0.8833467364311218
  },
  {
    "title": "June 14th Options Now Available For Vertex Pharmaceuticals (VRTX)",
    "published": 1714731420,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 401.5,
      "2024-05-03T14:30:00+00:00": 399.70001220703125,
      "2024-05-03T15:30:00+00:00": 399.93499755859375,
      "2024-05-03T16:30:00+00:00": 400.2200012207031,
      "2024-05-03T17:30:00+00:00": 401.6600036621094,
      "2024-05-03T18:30:00+00:00": 402.04998779296875,
      "2024-05-03T19:30:00+00:00": 402.1099853515625
    },
    "sentiment": 0.9445434212684631
  },
  {
    "title": "Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street\u2019s Radar",
    "published": 1714699320,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 401.5,
      "2024-05-03T14:30:00+00:00": 399.70001220703125,
      "2024-05-03T15:30:00+00:00": 399.93499755859375,
      "2024-05-03T16:30:00+00:00": 400.2200012207031,
      "2024-05-03T17:30:00+00:00": 401.6600036621094,
      "2024-05-03T18:30:00+00:00": 402.04998779296875,
      "2024-05-03T19:30:00+00:00": 402.1099853515625
    },
    "sentiment": 0.87724369764328
  },
  {
    "title": "3 Biotech Stocks to Buy and Hold Through 2030 and Beyond",
    "published": 1714648500,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 402.8550109863281,
      "2024-05-02T14:30:00+00:00": 400.1000061035156,
      "2024-05-02T15:30:00+00:00": 401.68499755859375,
      "2024-05-02T16:30:00+00:00": 403.42999267578125,
      "2024-05-02T17:30:00+00:00": 401.6600036621094,
      "2024-05-02T18:30:00+00:00": 400.69000244140625,
      "2024-05-02T19:30:00+00:00": 400.82501220703125
    },
    "sentiment": 0.8805452585220337
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It",
    "published": 1714568412,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 392.80999755859375,
      "2024-05-01T14:30:00+00:00": 394.42999267578125,
      "2024-05-01T15:30:00+00:00": 396.4599914550781,
      "2024-05-01T16:30:00+00:00": 397.2650146484375,
      "2024-05-01T17:30:00+00:00": 399.864990234375,
      "2024-05-01T18:30:00+00:00": 401.114990234375,
      "2024-05-01T19:30:00+00:00": 405.135009765625
    },
    "sentiment": 0.9289575219154358
  },
  {
    "title": "Jennifer Schneider Elected to Vertex Board of Directors",
    "published": 1715783400,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 431.0,
      "2024-05-15T14:30:00+00:00": 433.54998779296875,
      "2024-05-15T15:30:00+00:00": 435.5199890136719,
      "2024-05-15T16:30:00+00:00": 436.4421081542969,
      "2024-05-15T17:30:00+00:00": 438.44000244140625,
      "2024-05-15T18:30:00+00:00": 437.32501220703125,
      "2024-05-15T19:30:00+00:00": 437.0350036621094
    },
    "sentiment": 0.9269466996192932
  },
  {
    "title": "Vertex Pharmaceuticals's Options Frenzy: What You Need to Know",
    "published": 1715743980,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 431.0,
      "2024-05-15T14:30:00+00:00": 433.54998779296875,
      "2024-05-15T15:30:00+00:00": 435.5199890136719,
      "2024-05-15T16:30:00+00:00": 436.4421081542969,
      "2024-05-15T17:30:00+00:00": 438.44000244140625,
      "2024-05-15T18:30:00+00:00": 437.32501220703125,
      "2024-05-15T19:30:00+00:00": 437.0350036621094
    },
    "sentiment": 0.9454261064529419
  },
  {
    "title": "3 Cheap Biotech Stocks to Buy Now: May 2024",
    "published": 1715696697,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 428.4525146484375,
      "2024-05-14T14:30:00+00:00": 426.70001220703125,
      "2024-05-14T15:30:00+00:00": 425.1744079589844,
      "2024-05-14T16:30:00+00:00": 423.0050048828125,
      "2024-05-14T17:30:00+00:00": 423.3608093261719,
      "2024-05-14T18:30:00+00:00": 425.7799987792969,
      "2024-05-14T19:30:00+00:00": 427.7099914550781
    },
    "sentiment": 0.9149845838546753
  },
  {
    "title": "Unveiling Vertex Pharmaceuticals (VRTX)'s Market Value: A Comprehensive Guide",
    "published": 1715679240,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 428.4525146484375,
      "2024-05-14T14:30:00+00:00": 426.70001220703125,
      "2024-05-14T15:30:00+00:00": 425.1744079589844,
      "2024-05-14T16:30:00+00:00": 423.0050048828125,
      "2024-05-14T17:30:00+00:00": 423.3608093261719,
      "2024-05-14T18:30:00+00:00": 425.7799987792969,
      "2024-05-14T19:30:00+00:00": 427.7099914550781
    },
    "sentiment": 0.80447918176651
  },
  {
    "title": "Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating",
    "published": 1715659800,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 428.4525146484375,
      "2024-05-14T14:30:00+00:00": 426.70001220703125,
      "2024-05-14T15:30:00+00:00": 425.1744079589844,
      "2024-05-14T16:30:00+00:00": 423.0050048828125,
      "2024-05-14T17:30:00+00:00": 423.3608093261719,
      "2024-05-14T18:30:00+00:00": 425.7799987792969,
      "2024-05-14T19:30:00+00:00": 427.7099914550781
    },
    "sentiment": 0.7267358303070068
  },
  {
    "title": "Vortex Energy Partners for Green Solutions in Newfoundland",
    "published": 1715600220,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 425.989990234375,
      "2024-05-13T14:30:00+00:00": 426.3500061035156,
      "2024-05-13T15:30:00+00:00": 427.07000732421875,
      "2024-05-13T16:30:00+00:00": 427.2049865722656,
      "2024-05-13T17:30:00+00:00": 427.32000732421875,
      "2024-05-13T18:30:00+00:00": 428.20001220703125,
      "2024-05-13T19:30:00+00:00": 429.0400085449219
    },
    "sentiment": 0.7077586650848389
  },
  {
    "title": "2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade",
    "published": 1715530800,
    "day_prices": {},
    "sentiment": 0.893114447593689
  },
  {
    "title": "Alpine Immune ticks higher as HSR waiting period for Vertex Pharma deal expires",
    "published": 1715341800,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 420.3999938964844,
      "2024-05-10T14:30:00+00:00": 419.5,
      "2024-05-10T15:30:00+00:00": 420.8999938964844,
      "2024-05-10T16:30:00+00:00": 420.5299987792969,
      "2024-05-10T17:30:00+00:00": 419.70001220703125,
      "2024-05-10T18:30:00+00:00": 421.7449951171875,
      "2024-05-10T19:30:00+00:00": 422.8999938964844
    },
    "sentiment": 0.4135361313819885
  },
  {
    "title": "CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss",
    "published": 1715266680,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 419.0,
      "2024-05-09T14:30:00+00:00": 417.510009765625,
      "2024-05-09T15:30:00+00:00": 417.0150146484375,
      "2024-05-09T16:30:00+00:00": 417.4849853515625,
      "2024-05-09T17:30:00+00:00": 418.2950134277344,
      "2024-05-09T18:30:00+00:00": 418.7200012207031,
      "2024-05-09T19:30:00+00:00": 420.0
    },
    "sentiment": 0.9562392830848694
  },
  {
    "title": "Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight",
    "published": 1715231091,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 419.0,
      "2024-05-09T14:30:00+00:00": 417.510009765625,
      "2024-05-09T15:30:00+00:00": 417.0150146484375,
      "2024-05-09T16:30:00+00:00": 417.4849853515625,
      "2024-05-09T17:30:00+00:00": 418.2950134277344,
      "2024-05-09T18:30:00+00:00": 418.7200012207031,
      "2024-05-09T19:30:00+00:00": 420.0
    },
    "sentiment": 0.9003154039382935
  },
  {
    "title": "Bluebird bio spikes even as CRISPR leads in gene therapy rollout",
    "published": 1715217240,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 419.0,
      "2024-05-09T14:30:00+00:00": 417.510009765625,
      "2024-05-09T15:30:00+00:00": 417.0150146484375,
      "2024-05-09T16:30:00+00:00": 417.4849853515625,
      "2024-05-09T17:30:00+00:00": 418.2950134277344,
      "2024-05-09T18:30:00+00:00": 418.7200012207031,
      "2024-05-09T19:30:00+00:00": 420.0
    },
    "sentiment": 0.8199981451034546
  },
  {
    "title": "Vertex Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations",
    "published": 1715171424,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 413.3299865722656,
      "2024-05-08T14:30:00+00:00": 422.8349914550781,
      "2024-05-08T15:30:00+00:00": 424.3399963378906,
      "2024-05-08T16:30:00+00:00": 419.95001220703125,
      "2024-05-08T17:30:00+00:00": 420.4700012207031,
      "2024-05-08T18:30:00+00:00": 424.0,
      "2024-05-08T19:30:00+00:00": 422.5899963378906
    },
    "sentiment": 0.9396857023239136
  },
  {
    "title": "Balancing Act: Vertex Pharmaceuticals\u2019 Growth Prospects and Valuation Concerns Justify a Hold Rating",
    "published": 1715161740,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 413.3299865722656,
      "2024-05-08T14:30:00+00:00": 422.8349914550781,
      "2024-05-08T15:30:00+00:00": 424.3399963378906,
      "2024-05-08T16:30:00+00:00": 419.95001220703125,
      "2024-05-08T17:30:00+00:00": 420.4700012207031,
      "2024-05-08T18:30:00+00:00": 424.0,
      "2024-05-08T19:30:00+00:00": 422.5899963378906
    },
    "sentiment": 0.5277761220932007
  },
  {
    "title": "Unveiling Vertex Pharmaceuticals (VRTX)'s Value: Is It Really Priced Right? A Comprehensive Guide",
    "published": 1715160720,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 413.3299865722656,
      "2024-05-08T14:30:00+00:00": 422.8349914550781,
      "2024-05-08T15:30:00+00:00": 424.3399963378906,
      "2024-05-08T16:30:00+00:00": 419.95001220703125,
      "2024-05-08T17:30:00+00:00": 420.4700012207031,
      "2024-05-08T18:30:00+00:00": 424.0,
      "2024-05-08T19:30:00+00:00": 422.5899963378906
    },
    "sentiment": 0.8037523627281189
  },
  {
    "title": "Vertex Pharmaceuticals Sell Rating Maintained Amid Unsustainable Performance and Uncertain Pipeline Progress",
    "published": 1715149980,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 413.3299865722656,
      "2024-05-08T14:30:00+00:00": 422.8349914550781,
      "2024-05-08T15:30:00+00:00": 424.3399963378906,
      "2024-05-08T16:30:00+00:00": 419.95001220703125,
      "2024-05-08T17:30:00+00:00": 420.4700012207031,
      "2024-05-08T18:30:00+00:00": 424.0,
      "2024-05-08T19:30:00+00:00": 422.5899963378906
    },
    "sentiment": 0.9619438052177429
  },
  {
    "title": "A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics",
    "published": 1715133060,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 413.3299865722656,
      "2024-05-08T14:30:00+00:00": 422.8349914550781,
      "2024-05-08T15:30:00+00:00": 424.3399963378906,
      "2024-05-08T16:30:00+00:00": 419.95001220703125,
      "2024-05-08T17:30:00+00:00": 420.4700012207031,
      "2024-05-08T18:30:00+00:00": 424.0,
      "2024-05-08T19:30:00+00:00": 422.5899963378906
    },
    "sentiment": 0.9067733287811279
  },
  {
    "title": "Walmart, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'",
    "published": 1716449580,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 449.8399963378906,
      "2024-05-23T14:30:00+00:00": 449.4649963378906,
      "2024-05-23T15:30:00+00:00": 450.9100036621094,
      "2024-05-23T16:30:00+00:00": 452.70001220703125,
      "2024-05-23T17:30:00+00:00": 451.1499938964844,
      "2024-05-23T18:30:00+00:00": 449.4599914550781,
      "2024-05-23T19:30:00+00:00": 449.8599853515625
    },
    "sentiment": 0.9466620087623596
  },
  {
    "title": "Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity",
    "published": 1716432720,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 449.8399963378906,
      "2024-05-23T14:30:00+00:00": 449.4649963378906,
      "2024-05-23T15:30:00+00:00": 450.9100036621094,
      "2024-05-23T16:30:00+00:00": 452.70001220703125,
      "2024-05-23T17:30:00+00:00": 451.1499938964844,
      "2024-05-23T18:30:00+00:00": 449.4599914550781,
      "2024-05-23T19:30:00+00:00": 449.8599853515625
    },
    "sentiment": 0.7057888507843018
  },
  {
    "title": "Stocks Step Back After Fed Minutes; Loar, Monday.com, VRTX In Focus",
    "published": 1716410452,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 442.5400085449219,
      "2024-05-22T14:30:00+00:00": 445.6499938964844,
      "2024-05-22T15:30:00+00:00": 446.6000061035156,
      "2024-05-22T16:30:00+00:00": 448.1400146484375,
      "2024-05-22T17:30:00+00:00": 449.9100036621094,
      "2024-05-22T18:30:00+00:00": 447.4100036621094,
      "2024-05-22T19:30:00+00:00": 447.2699890136719
    },
    "sentiment": 0.7358055710792542
  },
  {
    "title": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "published": 1716349620,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 442.5400085449219,
      "2024-05-22T14:30:00+00:00": 445.6499938964844,
      "2024-05-22T15:30:00+00:00": 446.6000061035156,
      "2024-05-22T16:30:00+00:00": 448.1400146484375,
      "2024-05-22T17:30:00+00:00": 449.9100036621094,
      "2024-05-22T18:30:00+00:00": 447.4100036621094,
      "2024-05-22T19:30:00+00:00": 447.2699890136719
    },
    "sentiment": 0.9419763088226318
  },
  {
    "title": "Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick",
    "published": 1716299412,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 446.0,
      "2024-05-21T14:30:00+00:00": 444.4800109863281,
      "2024-05-21T15:30:00+00:00": 440.7900085449219,
      "2024-05-21T16:30:00+00:00": 440.2300109863281,
      "2024-05-21T17:30:00+00:00": 437.95001220703125,
      "2024-05-21T18:30:00+00:00": 439.2749938964844,
      "2024-05-21T19:30:00+00:00": 439.92999267578125
    },
    "sentiment": 0.8873241543769836
  },
  {
    "title": "PTC Therapeutics rallies 18% on EU authorization update for Translarna",
    "published": 1716195600,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 444.7200012207031,
      "2024-05-20T14:30:00+00:00": 446.9049987792969,
      "2024-05-20T15:30:00+00:00": 446.80999755859375,
      "2024-05-20T16:30:00+00:00": 445.9100036621094,
      "2024-05-20T17:30:00+00:00": 446.9800109863281,
      "2024-05-20T18:30:00+00:00": 447.3299865722656,
      "2024-05-20T19:30:00+00:00": 446.3800048828125
    },
    "sentiment": 0.9447431564331055
  },
  {
    "title": "Is CRISPR Therapeutics Stock a Buy?",
    "published": 1715952600,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 442.0,
      "2024-05-17T14:30:00+00:00": 442.0299987792969,
      "2024-05-17T15:30:00+00:00": 442.2550048828125,
      "2024-05-17T16:30:00+00:00": 442.9549865722656,
      "2024-05-17T17:30:00+00:00": 443.25,
      "2024-05-17T18:30:00+00:00": 444.239990234375,
      "2024-05-17T19:30:00+00:00": 445.75
    },
    "sentiment": 0.9158287048339844
  },
  {
    "title": "How non-opioids could shake up the $75 billion pain-treatment industry",
    "published": 1715828400,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 434.5899963378906,
      "2024-05-16T14:30:00+00:00": 436.19000244140625,
      "2024-05-16T15:30:00+00:00": 436.9700012207031,
      "2024-05-16T16:30:00+00:00": 438.0799865722656,
      "2024-05-16T17:30:00+00:00": 438.2950134277344,
      "2024-05-16T18:30:00+00:00": 438.1099853515625,
      "2024-05-16T19:30:00+00:00": 439.8500061035156
    },
    "sentiment": 0.8330111503601074
  }
]